0.8276
price down icon0.17%   -0.0014
after-market Handel nachbörslich: .80 -0.0276 -3.33%
loading

Finanzdaten der Palisade Bio Inc-Aktie (PALI)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
-
- - - 0.25
Operating Expenses
16.46%
3.673
3.154 3.778 3.609 2.779
Interest Income/Expense
75.00%
0.001
0.004 0.008 0.003 -
Operating Income/Loss
16.46%
-3.673
-3.154 -3.778 -3.609 -2.529
Nonoperating Income/Loss
20.22%
0.146
0.183 0.182 0.216 0.189
Income/Loss From Continuing Operations Before Tax
-3.527
- -3.596 -3.393 0.25
Income/Loss From Continuing Operations After Tax
18.71%
-3.527
-2.971 -3.596 -3.393 -2.34
Net Income/Loss
18.71%
-3.527
-2.971 -3.596 -3.393 -2.34
Preferred Stock Dividends And Other Adjustments
-
- 0.016 - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
5.06%
0.7681
0.8091 7.3444 6.4179 4.3155
Diluted Average Shares
5.06%
0.7681
0.8091 7.3444 6.4179 4.3155
Basic Earnings Per Share
1,736%
-4.59
-0.25 -0.49 -0.53 -0.54
Diluted Earnings Per Share
1,736%
-4.59
-0.25 -0.49 -0.53 -0.54
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- 0.016 - -
$310.03
price down icon 3.13%
$19.13
price down icon 7.54%
$22.96
price up icon 1.23%
$33.86
price up icon 0.65%
biotechnology ONC
$245.53
price down icon 9.67%
$111.56
price down icon 1.20%
Kapitalisierung:     |  Volumen (24h):